The Fund seeks to track the price and total return performance, before fees and expenses, of the Vident Core US Equity Index. The Fund attempts to invest its assets in common stocks that make up the Strategy Index. The Fund will invest at least 80% of its total assets in component securities of the Strategy Index.
- 1 Week
- 1 Month
- 3 Months
- 1 Yr Return
- 5 Yr Return
|Oil & Gas||4.45%|
Top 10 Holdings
|Symbol||Company Name||% Of Assets|
|ARCB||ArcBest Corp ORD||0.77%|
|ACI||Albertsons Companies Inc ORD||0.75%|
|HRI||Herc Holdings Inc ORD||0.74%|
|CIVI||Civitas Resources Inc ORD||0.71%|
|WLL||Whiting Petroleum Corp ORD||0.66%|
|OVV||Ovintiv Inc ORD||0.66%|
|ATKR||Atkore Inc ORD||0.65%|
|JEF||Jefferies Financial Group Inc ORD||0.65%|
|PDCE||PDC Energy Inc ORD||0.64%|
|HRC||Hill-Rom Holdings Inc ORD||0.63%|
|Name||Vident Core US Equity|
|Market Capitalization||26.62 B|
|Total Net Assets||439.10|
|Sub Asset Class||Mid-Cap Value Funds|
|Number Of Holdings||226|
Master The Market with the Help of Our Financial Experts
Recent Articles from TheStreet
Intel Leads Tech Surge, Dow Futures Higher As Investors Look Past Omicron Risks
Wall Street looks set to recoup all -- and more -- of last week's Omicron-linked declines as investors look past risks tied to the new variant, which may be milder and less virulent that first anticipated.
American Airlines CEO Doug Parker to Retire, Robert Isom Named New Boss
Doug Parker, American Airlines' long-serving CEO, will retire in March of next year, the carrier confirmed Tuesday.
GlaxoSmithKline, Vir Biotechnology Say COVID Therapy Effective Against Omicron Variant
GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new Omicron variant.
Tesla Stock Gains After Elon Musk Disses Biden's EV Bill
Tesla shares are set to snap a four-day losing streak after Elon Musk says Congress should not approve the Biden infrastructure bill that includes EV subsidies.
Intel Stock Surges On Plans For Potential $50 Billion Mobileye IPO
Intel plans to list Mobileye, the self-driving car division is purchased in 2017, sometime next year in a deal that could value the group at around $50 billion.
Intel, Samsung, Omicron, Tesla and Surging Stock Markets - 5 Things You Must Know
Stocks futures extend gains as Omicron risks fade, Glaxo and Vir Bio say COVID therapy effective against variant; Intel plans potential $50 billion Mobileye IPO; Samsung merges phone and electronics division in major restructuring and Elon Musk says Biden's EV incentives shouldn't pass congress.
Tech Stocks are Facing a Reckoning After Months of Rapid Gains
But some chip names still have relatively low valuations.